米国の末梢血管造影剤市場規模、シェア、動向分析レポート：モダリティ別、製品別、最終用途別、セグメント別予測、2025～2030年

米国の末梢血管造影剤市場の成長と動向

Grand View Research, Incの最新レポートによると、米国の末梢血管造影剤市場規模は2030年までに3億3,181万米ドルに達し、2025～2030年のCAGRは6.29％で拡大すると予測されています。

特に高齢化社会と糖尿病、高血圧、肥満などの生活習慣病患者の間で血管疾患の有病率が上昇していることが、先進的画像診断の需要を促進しています。造影剤を利用して血管の可視性を高める末梢血管造影法は、末梢動脈疾患やその他の循環障害の早期発見と正確な診断に不可欠です。

糖尿病、肥満、高血圧、喫煙などの生活習慣病は世界的に一般化しています。これらの疾患は末梢血管疾患の開発リスクを著しく増加させています。例えば、糖尿病や高血圧は血管を傷つけ、血管合併症を引き起こす可能性が高くなります。このような生活習慣病患者数が世界的に増加し続けているため、それに伴い画像診断の需要も増加しています。造影剤を利用して血管の鮮明で詳細な画像を提供する末梢血管造影は、これらの疾患を診断し、タイムリーな医療介入を可能にする上で極めて重要です。このような生活習慣病有病率の増加は、血管造影剤の需要を直接的に促進します。イェディテペ大学病院によると、2025年までに高血圧患者は15億人に達すると予想されています。60歳以上の3人に1人が高血圧です。

しかし、市場の成長を抑制する主要要因の一つは、画像診断、特に血管造影のコストが高いことです。末梢血管造影に使用されるような先進的画像診断技術には、高価な機器、熟練したスタッフ、特殊な造影剤が必要です。この高額な費用は、特に医療予算が少ない地域では、これらの手技へのアクセスを制限し、一部の患者や医療提供者が診断的血管造影を選択することを躊躇させる可能性があります。さらに、十分な保険が適用されない患者は自己負担額に直面する可能性があり、これらのサービスに対する全体的な需要を減少させています。

米国の末梢血管造影剤市場レポートハイライト

• 製品別では、CT/X線セグメントが2024年の市場を独占し、2025～2030年にかけて大きなCAGRを記録すると予測されます。先天性心疾患（CHD）の有病率の上昇により、CTアンギオグラフィの需要が大幅に増加しています。
• モダリティ別では、X線、CT、血管造影などの画像モダリティで血管の可視性を高める効果が高いヨード系造影剤が市場を独占しています。
• 最終用途別では、2024年に病院セグメントが市場を席巻し、予測期間中に大きな成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の末梢血管造影剤市場の変数、動向、範囲

• 市場系統の展望
  • 補助市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 米国の末梢血管造影造影剤市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 米国の末梢血管造影剤市場：製品別、推定・動向分析

• セグメントダッシュボード
• 米国の末梢血管造影剤市場変動分析
• 米国の末梢血管造影造影剤市場規模と動向分析、製品別、2018～2030年
• CT/X線
• 磁気共鳴画像
• 超音波

第5章 米国の末梢血管造影剤市場：モダリティ別、推定・動向分析

• セグメントダッシュボード
• 米国の末梢血管造影剤市場変動分析
• 米国の末梢血管造影剤市場規模と動向分析、モダリティ別、2018～2030年
• ヨード造影剤
• ガドリニウム造影剤
• マイクロバブル

第6章 米国の末梢血管造影剤市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 米国の末梢血管造影剤市場変動分析
• 米国の末梢血管造影剤市場規模と動向分析、最終用途別、2018～2030年
• 病院
• 画像診断センター
• 研究機関
• その他

第7章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2024年
• 主要な認証プロバイダー/スキーム所有者一覧
• 企業プロファイル/上場企業
  • Lantheus Holdings, Inc.
  • Guerbet
  • Bracco
  • Bayer
  • GE HealthCare
  • Fresenius Kabi USA

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Peripheral Vascular Angiography Contrast Media Market, by Product, 2018 - 2030 (USD Million)
• Table 4 U.S. Peripheral Vascular Angiography Contrast Media Market, by Modality, 2018 - 2030 (USD Million)
• Table 5 U.S. Peripheral Vascular Angiography Contrast Media Market, by End Use, 2018 - 2030 (USD Million)
• Table 6 Participant's Overview
• Table 7 Financial Performance
• Table 8 Product Benchmarking
• Table 9 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Peripheral Vascular Angiography Contrast Media Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Product Marketplace: Key Takeaways
• Fig. 14 U.S. Peripheral Vascular Angiography Contrast Media Market, for CT/X-ray, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Peripheral Vascular Angiography Contrast Media Market, for Magnetic Resonance Imaging, 2018 - 2030 (USD Million)
• Fig. 16 U.S. Peripheral Vascular Angiography Contrast Media Market, for Ultrasound, 2018 - 2030 (USD Million)
• Fig. 17 Modality Marketplace: Key Takeaways
• Fig. 18 U.S. Peripheral Vascular Angiography Contrast Media Market, for Iodinated Contrast Media, 2018 - 2030 (USD Million)
• Fig. 19 U.S. Peripheral Vascular Angiography Contrast Media Market, for Gadolinium-based Contrast Media, 2018 - 2030 (USD Million)
• Fig. 20 U.S. Peripheral Vascular Angiography Contrast Media Market, for Microbubble, 2018 - 2030 (USD Million)
• Fig. 21 End Use Marketplace: Key Takeaways
• Fig. 22 U.S. Peripheral Vascular Angiography Contrast Media Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 23 U.S. Peripheral Vascular Angiography Contrast Media Market, for Diagnostic Imaging Centers, 2018 - 2030 (USD Million)
• Fig. 24 U.S. Peripheral Vascular Angiography Contrast Media Market, for Research Institutes, 2018 - 2030 (USD Million)
• Fig. 25 U.S. Peripheral Vascular Angiography Contrast Media Market, for Others, 2018 - 2030 (USD Million)

U.S. Peripheral Vascular Angiography Contrast Media Market Growth & Trends:

The U.S. peripheral vascular angiography contrast media market size is anticipated to reach USD 331.81 million by 2030 expanding at a CAGR of 6.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of vascular diseases, particularly among the aging population and individuals with lifestyle-associated conditions such as diabetes, hypertension, and obesity, is driving demand for advanced diagnostic imaging. Peripheral vascular angiography procedures, which utilize contrast agents to enhance the visibility of blood vessels, are essential for the early detection and accurate diagnosis of peripheral artery disease and other circulatory disorders.

Lifestyle-associated diseases, such as diabetes, obesity, hypertension, and smoking, are becoming more common worldwide. These conditions significantly increase the risk of developing peripheral vascular diseases. For instance, diabetes and hypertension can damage blood vessels, leading to a higher likelihood of vascular complications. As the number of individuals living with these lifestyle-related conditions continues to grow globally, there is an associated rise in the demand for diagnostic imaging. Peripheral vascular angiography, which utilizes contrast media to provide clear and detailed images of the blood vessels, is crucial in diagnosing these conditions and enabling timely medical interventions. This increasing prevalence of lifestyle-related disorders directly drives the demand for angiography contrast media. According to Yeditepe University Hospital, by 2025, hypertension patients are expected to reach 1.5 billion. 1 in 3 people over the age of 60 have hypertension.

However, one of the major factors restraining the growth of the market is the high cost of diagnostic imaging procedures, particularly angiography. Advanced imaging technologies, such as those used in peripheral vascular angiography, require expensive equipment, skilled personnel, and specialized contrast media. This high cost can limit access to these procedures, particularly in regions with lower healthcare budgets, and may deter some patients or healthcare providers from opting for diagnostic angiography. Moreover, patients without adequate insurance coverage may face out-of-pocket costs, reducing the overall demand for these services.

U.S. Peripheral Vascular Angiography Contrast Media Market Report Highlights:

• Based on the product, The CT/X-ray segment dominated the market in 2024 and is expected to register a significant CAGR from 2025 to 2030. The rising prevalence of congenital heart diseases (CHDs) significantly increases the demand for CT angiography.
• Based on the modality, Iodinated contrast media dominate the market due to their high efficacy in enhancing the visibility of blood vessels in imaging modalities such as X-ray, CT, and angiography.
• Based on end use, the hospital segment dominated the market in 2024, and it is expected to witness significant growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Angiography Contrast Media Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing burden of peripheral artery disease
    • 3.2.1.2. Rising demand for medical imaging
    • 3.2.1.3. Increasing prevalence of aging population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost associated with angiography procedures
    • 3.2.2.2. Complications associated with the use of contrast agent during procedures
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Rising number of clinical trials
    • 3.2.3.2. Growing prevalence of lifestyle associated disorders
    • 3.2.3.3. Increasing regulatory approvals and launches among developed countries
  • 3.2.4. Market Challenge Analysis
• 3.3. U.S. Peripheral Vascular Angiography Contrast Media Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining Power Of Suppliers
    • 3.3.1.2. Bargaining Power Of Buyers
    • 3.3.1.3. Threat Of Substitutes
    • 3.3.1.4. Threat Of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological Landscape

Chapter 4. U.S. Peripheral Vascular Angiography Contrast Media Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
• 4.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. CT/X-ray
  • 4.4.1. CT/X-ray U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Magnetic Resonance Imaging
  • 4.5.1. Magnetic Resonance Imaging U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Ultrasound
  • 4.6.1. Ultrasound U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Vascular Angiography Contrast Media Market: Modality Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
• 5.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
• 5.4. Iodinated Contrast Media
  • 5.4.1. Iodinated Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Gadolinium-based Contrast Media
  • 5.5.1. Gadolinium-based Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Microbubble
  • 5.6.1. Microbubble U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Vascular Angiography Contrast Media Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
• 6.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Diagnostic Imaging Centers U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Research Institutes
  • 6.6.1. Research Institutes U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company/Competition Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. List of Key Certification Providers/Scheme Owners
• 7.5. Company Profiles/Listing
  • 7.5.1. Lantheus Holdings, Inc.
    • 7.5.1.1. Company overview
    • 7.5.1.2. Financial performance
    • 7.5.1.3. Product Type benchmarking
    • 7.5.1.4. Strategic initiatives
  • 7.5.2. Guerbet
    • 7.5.2.1. Company overview
    • 7.5.2.2. Financial performance
    • 7.5.2.3. Product Type benchmarking
    • 7.5.2.4. Strategic initiatives
  • 7.5.3. Bracco
    • 7.5.3.1. Company overview
    • 7.5.3.2. Financial performance
    • 7.5.3.3. Product Type benchmarking
    • 7.5.3.4. Strategic initiatives
  • 7.5.4. Bayer
    • 7.5.4.1. Company overview
    • 7.5.4.2. Financial performance
    • 7.5.4.3. Product Type benchmarking
    • 7.5.4.4. Strategic initiatives
  • 7.5.5. GE HealthCare
    • 7.5.5.1. Company overview
    • 7.5.5.2. Financial performance
    • 7.5.5.3. Product Type benchmarking
    • 7.5.5.4. Strategic initiatives
  • 7.5.6. Fresenius Kabi USA
    • 7.5.6.1. Company overview
    • 7.5.6.2. Financial performance
    • 7.5.6.3. Product Type benchmarking
    • 7.5.6.4. Strategic initiatives